Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bicarbonate precursors are a class of organic anions, such as lactate, acetate, and citrate, that serve as metabolic substrates for the endogenous production of bicarbonate ions (NIH, 2017). These substances are not individual molecular targets like receptors or enzymes but are instead therapeutic agents used to manage the body's acid-base balance (ResearchGate, 2012). Upon administration, typically via intravenous fluids like Lactated Ringer's or Plasma-Lyte, these precursors undergo oxidative metabolism—primarily in the liver or peripheral tissues—to produce bicarbonate, which acts as a buffer to neutralize excess hydrogen ions (NIH, 2023). This mechanism is essential for treating conditions such as metabolic acidosis, renal failure, and severe dehydration where the body's natural buffering capacity is overwhelmed (StatPearls, 2023). In clinical settings, specific precursors are chosen based on the patient's metabolic capacity; for instance, acetate is often preferred over lactate in patients with hepatic impairment due to its more rapid and widespread metabolism (MDPI, 2024). While these agents are effective for restoring physiological pH, their use carries risks such as metabolic alkalosis, fluid overload, and electrolyte imbalances like citrate-induced hypocalcemia (NIH, 2025).
Bicarbonate precursors are organic anions that undergo metabolic conversion (primarily in the liver or peripheral tissues) to produce bicarbonate ions (HCO3-). This process consumes hydrogen ions or produces bicarbonate directly, thereby increasing the blood's buffering capacity and correcting metabolic acidosis.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bicarbonate Precursor.